These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18294468)

  • 1. Luminal narrowing after sirolimus-eluting stent implantation for in-stent restenosis using intravascular ultrasound.
    Kaneda H
    Am Heart J; 2008 Mar; 155(3):e23; author reply e21. PubMed ID: 18294468
    [No Abstract]   [Full Text] [Related]  

  • 2. Late restenosis following placement of a sirolimus eluting stent for in-stent restenosis.
    Ali OA; Lowe H; Kritharides L; Brieger D
    Heart Lung Circ; 2007 Feb; 16(1):50-1. PubMed ID: 17196881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial).
    Sakurai R; Ako J; Morino Y; Sonoda S; Kaneda H; Terashima M; Hassan AH; Leon MB; Moses JW; Popma JJ; Bonneau HN; Yock PG; Fitzgerald PJ; Honda Y;
    Am J Cardiol; 2005 Nov; 96(9):1251-3. PubMed ID: 16253592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No delayed restenosis at 18 months after implantation of sirolimus-eluting stent.
    Tanabe K; Degertekin M; Regar E; Ligthart JM; van der Giessen WJ; Serruys PW
    Catheter Cardiovasc Interv; 2002 Sep; 57(1):65-8. PubMed ID: 12203931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation.
    Kaneda H; Koizumi T; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ
    Am J Cardiol; 2005 Nov; 96(9):1237-41. PubMed ID: 16253589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of acute and long-term results and underlying mechanisms from sirolimus-eluting stent implantation for the treatment of in-stent restenosis and recurrent in-stent restenosis in patients in whom intracoronary radiation failed as assessed by intravascular ultrasound.
    Schiele TM; Rieber J; König A; Leibig M; Erhard I; Theisen K; Siebert U; Klauss V
    Am J Cardiol; 2004 Oct; 94(7):917-21. PubMed ID: 15464677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: a quantitative intravascular ultrasound analysis.
    Sakurai R; Ako J; Hassan AH; Bonneau HN; Neumann FJ; Desmet W; Holmes DR; Yock PG; Fitzgerald PJ; Honda Y
    Am Heart J; 2007 Aug; 154(2):361-5. PubMed ID: 17643589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
    Rensing BJ; Vos J; Smits PC; Foley DP; van den Brand MJ; van der Giessen WJ; de Feijter PJ; Serruys PW
    Eur Heart J; 2001 Nov; 22(22):2125-30. PubMed ID: 11686669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of late incomplete stent apposition: a comparison among bare-metal stents, intracoronary radiation and sirolimus-eluting stents.
    Miyazawa A; Tsujino I; Ako J; Shimada Y; Courtney BK; Sakurai R; Nakamura M; Okura H; Waseda K; Honda Y; Fitzgerald PJ
    J Invasive Cardiol; 2007 Dec; 19(12):515-8. PubMed ID: 18180522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Registry data evaluating the effectiveness of drug-eluting stents for the treatment of symptomatic in-stent restenosis.
    Worthley MI; Anderson TJ; Traboulsi M; Charbonneau F; Curtis MJ; Hansen JL; Knudtson ML; Spence FP; Goodhart DM
    Heart Lung Circ; 2006 Oct; 15(5):300-5. PubMed ID: 16877042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stents for the treatment of in-stent restenosis--'real world' double centre experience in consecutive patients.
    Anderson RA; Fath-Ordoubadi F; Younas S; Bainbridge A; Swallow RA; Dawkins KD; Curzen NP
    Int J Cardiovasc Intervent; 2005; 7(4):188-92. PubMed ID: 16373265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of long, diffuse in-stent restenosis with sirolimus-eluting stents.
    Li SS; So YC; Wong CH; Yiu SF; Chan KT
    J Invasive Cardiol; 2004 Feb; 16(2):81-3. PubMed ID: 14760198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting stent implantation in a heart transplant recipient.
    Tomai F; Gagliardi G; Proietti I
    Ital Heart J; 2004 May; 5(5):408-9. PubMed ID: 15185909
    [No Abstract]   [Full Text] [Related]  

  • 16. The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial).
    Moussa ID; Moses JW; Kuntz RE; Holmes DR; Popma JJ; Teirstein PS; Wong SC; Leon MB
    Am J Cardiol; 2006 Jun; 97(11):1582-4. PubMed ID: 16728218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is late luminal loss an accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries?
    Agostoni P; Valgimigli M; Abbate A; Cosgrave J; Pilati M; Biondi-Zoccai GG
    Am J Cardiol; 2006 Mar; 97(5):603-5. PubMed ID: 16490421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.
    Aoki J; Nakazawa G; Tanabe K; Hoye A; Yamamoto H; Nakayama T; Onuma Y; Higashikuni Y; Otsuki S; Yagishita A; Yachi S; Nakajima H; Hara K
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):380-6. PubMed ID: 17195199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
    Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
    Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents.
    Muñoz JS; Abizaid A; Mintz GS; Albertal M; Abizaid AS; Feres F; Centemero M; Staico R; Mattos LA; Pinto I; Sousa A; Sousa JE
    Am J Cardiol; 2004 Feb; 93(4):470-3. PubMed ID: 14969627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.